Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus(TM) Valve System

Source :: PR Newswire. September 23, 2014
Publication Year :: 2014
Abstract: Data From REPRISE III Clinical Trial Designed to Support U.S. Regulatory Approval MARLBOROUGH, Mass., Sept. 23, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the REPRISE III clinical [...]

Subjects :: Boston Scientific Corp. -- Product development
Medical test kit industry -- Product development
Medical equipment and supplies industry -- Product development
Business
News, opinion and commentary

Tools